Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia

By Harvey P.D.   Meltzer H.   Simpson G.M.   Potkin S.G.   Loebel A.   Siu C.   Romano S.J.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 101-113

Elsevier

Access to resources Recommend Favorite

Effects of amisulpride on the cognitive function of patients with schizophrenia who switched from risperidone

By Wang Yu-Ting   Chiu Nan-Ying   Jou Shaw-Hwa   Kuang Yang Yen   Hui Lee I   Wang Ching-Cheng   Ching Chen Kao   Liao Yi-Cheng  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 180-186

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A comparison of olanzapine versus risperidone for the treatment of schizophrenia: a meta-analysis of randomised clinical trials

By Mudge Mia   Davey Peter   Coleman Dr Kristina   Montgomery William   Croker Victoria   Mullen Karen   Castle David  

International Journal of Psychiatry in Clinical Practice, Vol. 9, Iss. 1, 2005-03 ,pp. : 3-15

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine

By Littrell K.H.   Petty R.G.   Hilligoss N.M.   Kirshner C.D.   Johnson C.G.  

Schizophrenia Research, Vol. 66, Iss. 2, 2004-02 ,pp. : 201-202

Elsevier

Access to resources Recommend Favorite

Metabolic effects of olanzapine and risperidone in patients with psychotic disorders

By Safa Mitra   Sadr Saeed   Delfan Bahram   Saki Mandana   Javad Tarrahi Mohammad  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 4, 2008-01 ,pp. : 299-302

Ashgate Publishing Ltd

Access to resources Recommend Favorite